Vimarsana
Biggest News Aggregation in the World

Phil Burcham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phil Burcham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phil Burcham Today - Breaking & Trending Today

Australian Utilitarianism Diminishing the Hippocratic Oath - Vimarsana News

Australian Utilitarianism Diminishing the Hippocratic Oath

Commentary Assuming we still aspire to live in societies governed by rational standards, we must try to explain ...

Vaccine Scrutiny Dies Where Institutional Indifference Reigns - Vimarsana News

Vaccine Scrutiny Dies Where Institutional Indifference Reigns

Commentary A recent trip to a local hairdresser’s shop exposed the tensions that are straining the bonds of ...

Hammond-based Neuro Vigor partners with Australian university to develop neurodegenerative disease drugs - Vimarsana News

Hammond-based Neuro Vigor partners with Australian university to develop neurodegenerative disease drugs

Hammond-based biotechnology firm Neuro Vigor reached a deal with the University of Western Australia to develop drugs to treat neurodegenerative diseases and pain in spinal cord injury.

Hammond-based Neuro Vigor partners with Australian university to develop neurodegenerative diseases - Vimarsana News

Hammond-based Neuro Vigor partners with Australian university to develop neurodegenerative diseases

Hammond-based biotechnology firm Neuro Vigor reached a deal with the University of Western Australia to develop drugs to treat neurodegenerative diseases and pain in spinal cord injury.

Neuro Vigor and the University of Western Australia announce drug development collaboration agreement - Vimarsana News

Neuro Vigor and the University of Western Australia announce drug development collaboration agreement

Neuro Vigor, a Purdue University-affiliated biotechnology company developing drugs that neutralize reactive aldehydes, announced Tuesday (Oct. 26) a collaboration agreement with the University of Western Australia to jointly develop proprietary drugs to initially target neurodegenerative diseases and pain in spinal cord injury, or SCI.

Source: purdue.edu